GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] proposal — a flair for glucagon posts — 30 comments in the full submission. View in context.
5k
c/retatrutide·submitted 1 year ago by u/solene_ilunga

[Meta] proposal — a flair for glucagon posts

Cautionbranch of 9 comments

I have had 5 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 24 days on nominally the same lane, which matters more in summer than in February. The independent number came back 97.9% against a claimed…

Read the full submission and all 30 comments →

This branch

9 comments, started 1 year ago
u/soren_nkemelu295 points·1 year ago

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

replysharereportpermalink
u/blunt_coldbox_2024401 points·1 year ago

What was the dosing schedule in that arm?

replysharereportpermalink
[deleted]126 points·1 year ago

[deleted]

replysharereportpermalink
u/solene_ilungaOP216 points·1 year ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
u/divya_bakken-7 points·1 year ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/titration_marshalmod · c/semaglutide176 points·1 year ago·edited

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/sofia_wikstrom210 points·1 year ago

nobody should be giving this to anyone without extensive monitoring

replysharereportpermalink
u/injection_site_iris110 points·1 year ago

the weight curves are unusually steep, which makes predicting individual response harder

replysharereportpermalink
u/emil_agyeman69 points·1 year ago·edited

triple agonism is phase 2, do not generalise

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.